Patent · US Expired

Therapeutical treatments

US6660722B2 · kind B2 · utility

8Cited by
0References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 30, 2001
Grant dateDec 9, 2003
Priority date
Expiry dateNov 30, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Therapeutical method comprising administration to a patient of an effective amount of especially soluble laminarin for the treatment of tumors and more generally of cancers of the group comprising breast cancer, lung cancer, oesophagus cancer, stomach cancer, intestine and colon cancers, and for the treatment of viral, bacterial and fungal diseases as well as diseases related to immunostimulant deficiencies of human beings and warm-blood animals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.